529.70

0.73% 3.82

After Hours: 530.00 0.30 +0.06%

Hca Healthcare Inc (HCA)

Overview News Price History Option Chain Financials Why HCA Down? Discussions Forecast Dividend History

Hca Healthcare Inc stock is traded at $529.70, with a volume of 2.29M. It is up +0.73% in the last 24 hours and up +4.72% over the past month. HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.

Previous Close:

$525.88

Open:

$525.73

24h Volume:

2.29M

Relative Volume:

1.91

Market Cap:

$118.45B

Revenue:

$75.60B

Net Income/Loss:

$7.78B

P/E Ratio:

18.66

EPS:

28.3842

Net Cash Flow:

$7.69B

1W Performance:

-0.49%

1M Performance:

+4.72%

6M Performance:

+30.77%

1Y Performance:

+65.05%

1-Day Range:

$523.10

$532.69

1-Week Range:

$522.05

$547.05

52-Week Range:

$295.00

$552.90

Hca Healthcare Inc Stock (HCA) Company Profile

Name

Hca Healthcare Inc

Sector

Healthcare (1111)

Industry

Medical Care Facilities (51)

Phone

(615) 344-9551

Address

ONE PARK PLZ, NASHVILLE, TN

Employee

320,000

Twitter

@hcahealthcare

Next Earnings Date

2026-01-27

Latest SEC Filings

HCA's Discussions on Twitter

Compare HCA vs THC, FMS, UHS, ENSG

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HCA Hca Healthcare Inc	529.70	117.60B	75.60B	7.78B	7.69B	28.38
THC Tenet Healthcare Corp	239.39	20.84B	20.69B	2.40B	1.55B	15.62
FMS Fresenius Medical Care Ag Adr	23.46	13.08B	21.23B	924.30M	2.22B	1.2272
UHS Universal Health Services Inc	206.10	12.77B	16.08B	1.20B	1.06B	17.82
ENSG Ensign Group Inc	214.17	12.36B	4.11B	239.98M	193.10M	4.12

Hca Healthcare Inc Stock (HCA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-15-25	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Oct-14-25	Resumed	Goldman	Buy
Jul-28-25	Downgrade	Wolfe Research	Outperform → Peer Perform
Jul-16-25	Downgrade	BofA Securities	Buy → Neutral
May-29-25	Upgrade	Wells Fargo	Underweight → Equal Weight
Apr-15-25	Downgrade	Robert W. Baird	Outperform → Neutral
Dec-17-24	Resumed	JP Morgan	Neutral
Nov-25-24	Downgrade	Wells Fargo	Equal Weight → Underweight
Nov-22-24	Downgrade	Raymond James	Outperform → Mkt Perform
Oct-11-24	Initiated	KeyBanc Capital Markets	Overweight
Sep-03-24	Initiated	Morgan Stanley	Equal-Weight
May-30-24	Initiated	Robert W. Baird	Outperform
Mar-06-24	Initiated	Barclays	Overweight
Jan-04-24	Downgrade	Bernstein	Outperform → Mkt Perform
Dec-11-23	Downgrade	Goldman	Buy → Neutral
Apr-21-23	Initiated	Cantor Fitzgerald	Overweight
Apr-19-23	Resumed	JP Morgan	Neutral
Jul-06-22	Downgrade	BMO Capital Markets	Market Perform → Underperform
Jun-17-22	Initiated	Loop Capital	Buy
May-27-22	Upgrade	Bernstein	Mkt Perform → Outperform
Mar-29-22	Initiated	Wells Fargo	Equal Weight
Jan-10-22	Resumed	Citigroup	Buy
Dec-21-21	Downgrade	JP Morgan	Overweight → Neutral
Sep-27-21	Initiated	SVB Leerink	Outperform
Sep-24-21	Initiated	UBS	Buy
Sep-10-21	Initiated	Cowen	Outperform
Aug-12-21	Downgrade	Barclays	Overweight → Equal Weight
Jul-09-21	Initiated	Seaport Global Securities	Buy
May-13-21	Resumed	Citigroup	Neutral
Apr-26-21	Downgrade	Citigroup	Buy → Neutral
Dec-15-20	Initiated	Goldman	Buy
Dec-14-20	Upgrade	JP Morgan	Neutral → Overweight
Sep-21-20	Downgrade	JP Morgan	Overweight → Neutral
Jul-13-20	Downgrade	BMO Capital Markets	Outperform → Market Perform
Sep-06-19	Upgrade	BofA/Merrill	Underperform → Neutral
Jul-10-19	Upgrade	Goldman	Neutral → Buy
Apr-23-19	Upgrade	Raymond James	Mkt Perform → Outperform
Jan-14-19	Initiated	Stephens	Overweight
Jan-03-19	Initiated	Deutsche Bank	Buy
Nov-16-18	Initiated	UBS	Buy
Mar-23-18	Resumed	Mizuho	Buy
Jan-03-18	Initiated	Goldman	Neutral
Jan-03-18	Downgrade	Piper Jaffray	Overweight → Neutral
Dec-20-17	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Dec-12-17	Upgrade	Citigroup	Neutral → Buy
Nov-30-17	Upgrade	JP Morgan	Neutral → Overweight
Nov-06-17	Reiterated	Citigroup	Neutral
Nov-01-17	Reiterated	Mizuho	Buy
Jul-26-17	Downgrade	BofA/Merrill	Buy → Neutral
Jun-28-17	Initiated	Argus	Buy

View All

Hca Healthcare Inc Stock (HCA) Latest News

Feb 27, 2026

HCA's TriStar Division eyes Fairview for $21M freestanding ER - The Business Journals

Feb 27, 2026

This Fund Sold $38 Million in Appian Stock Last Quarter. Shares Have Fallen Over 25% This Year - The Motley Fool

Feb 27, 2026

How Is HCA Healthcare's Stock Performance Compared to Other Healthcare Providers Stocks? - FinancialContent

Feb 27, 2026

Part I: Northeast Florida health care development update: HCA, Baptist and Ascension St. Vincent's - Jacksonville Daily Record

Feb 27, 2026

Feb 26, 2026

Nurse sues HCA Florida Palms West Hospital, security company 1 year after brutal patient attack - WPTV

Feb 26, 2026

HCA Healthcare, Inc. to Present at March Conferences - The Joplin Globe

Feb 26, 2026

HCA Healthcare stock doubles in the three years, hitting new all-time high - The Business Journals

Feb 26, 2026

HCA Healthcare Named a World’s Most Admired Company by Fortune for the 12th Consecutive Year - Business Wire

Feb 26, 2026

Intech Investment Management LLC Sells 100,529 Shares of HCA Healthcare, Inc. $HCA - MarketBeat

Feb 26, 2026

Assessing HCA Healthcare (HCA) Valuation After Strong Recent Share Price Momentum - simplywall.st

Feb 26, 2026

Feb 25, 2026

HCA Healthcare (HCA) Announces 2026 Executive Officer Performanc - GuruFocus

Feb 25, 2026

A Look At HCA Healthcare (HCA) Valuation As AI Plans And Medicaid Updates Draw Analyst Upgrades - Yahoo Finance

Feb 25, 2026

HCA Healthcare announces 2026 executive performance plan and board retirement - Investing.com

Feb 25, 2026

HCA Healthcare Adopts 2026 Executive Performance Incentive Program - TipRanks

Feb 25, 2026

Robert J. Dennis to Retire from HCA Healthcare Board; Executive Officer PEP Adopted - TradingView

Feb 25, 2026

HCA Healthcare (HCA) Receives Price Target Boost from Mizuho Ana - GuruFocus

Feb 25, 2026

Mizuho Raises HCA Healthcare (NYSE:HCA) Price Target to $585.00 - MarketBeat

Feb 25, 2026

Mizuho Securities Adjusts HCA Healthcare PT to $585 From $540, Maintains Outperform Rating - marketscreener.com

Feb 25, 2026